Biome Australia Ltd · ASX:BIO
Biome Australia — Investor Presentation (December 2021)
34 slides from Biome Australia's investor presentation, Dec 3, 2021
Slide 1: Biome Australia Limited Investor Presentation
For personal use only Biome Australia Limited Investor Presentation December 2021
Slide 2: Disclaimer
Disclaimer This presentation and the information contained Past performance information included in this The recipient must, and agrees with the For personal use only within it (the “information”) has been prepared presentation is provided for illustrative purposes Company that it will, make its own
Slide 3: Executive Summary
Executive Summary Live biotherapeutic probiotics and complementary medicines supported by clinical evidence For personal use only ● Activated Probiotics® supported by randomised double-blind placebo-controlled trials ● R&D to support continued commercialisation, including 2 new clinical trials under
Slide 4: Who are we?
Who are we? For personal use only Biome Australia - The Microbiome Health Company Commercial in confidence PG.4
Slide 5: Our Vision, Mission and What We Do
Our Vision What We Do To prevent disease and improve quality of ● Research, development and commercialisation of clinically backed complementary medicines For personal use only life. ● Aim to improve health outcomes for customers Our Mission To prevent disease and improve health and ● Utilising trus
Slide 6: Certified B Corporation
Certified B Corporation For personal use only On 18 November 2021 Biome was certified as a B Corporation. Certified B Corporations are “businesses that meet the highest standards of verified social and environmental performance, public transparency, and legal accountability to balance profit and pur
Slide 7: What is our addressable market?
What is our addressable For personal use only market? Market size and opportunity Commercial in confidence PG.7
Slide 8: The Market Opportunity - Complementary Medicine
The Market Opportunity - Complementary Medicine Biome has an addressable market of $4.6bn in the complementary medicine industry For personal use only Complementary medicines industry estimated to be Industry has seen a period of strong growth and worth $5.69b in FY21 doubles over the last decade 7
Slide 9: The Market Opportunity - Adjunct to Medications
The Market Opportunity - Adjunct to Medications Secondary market with high barrier of entry For personal use only Given the high level of clinical evidence associated with Biome Australia products, Biome Australia has created a secondary market within community pharmacy. When a pharmacist prescribes
Slide 10: What we do? Where we do it?
What we do? For personal use only Where we do it? Biome’s products & go to market strategy Commercial in confidence PG.10
Slide 11: Products Supported by Clinical Evidence
Products Supported by Clinical Evidence IP and Research For personal use only 23 products in portfolio and growing • Biome Australia’s key live biotherapeutic products and a key nutraceutical product are supported by clinical evidence of efficacy - A number of live biotherapeutic products (AP and AX
Slide 12: Biome Eczema Probiotic - Patient Results
Biome Eczema Probiotic - Patient Results For personal use only “Jude and his mum has said thank you so much. They had tried every skin cream/soap/tablet and nothing has worked up until now. If you recall, Jude told one of the boys at school who asked what was wrong with his skin that he didn’t need
Slide 13: Practitioner's Feedback
Practitioner’s Feedback For personal use only Jade Walker Telmar Emilsdottir - Naturopath BHsC Naturopath BIOME IRON + PROBIOTIC BIOME ADVANCED PROBIOTIC Using Activated Probioitcs has been a game changer in my clinic. In particular, Just wanted to tell you about my client. She was diagnosed with br
Slide 14: Activated Probiotics
Activated Probiotics Biome OsteoTM Biome BreatheTM Practitioners & Pharmacies Probiotic Probiotic To help stimulate a healthy To help promote bone For personal use only immune system response in health in adults COMPETITIVE ADVANTAGE children Microencapsulation technology - supports 5x greater survi
Slide 15: Activated Probiotics Range - Health Functions
Activated Probiotics R Range – Health Functions Broad category coverage For personal use only Gut Health / IBS / Immune Health Antibiotic Recovery Female Health Infant and Child Condition Specific Inflammation Biome Daily X X X Biome Daily Kids X X X X Biome Lift X X X X Biome Advanced X X X Biome O
Slide 16: Activated Nutrients
Activated Nutrients Top Up Women Multivitamin+ Top Up Men Multivitamin+ Practitioners & Pharmacies A certified organic, vegan daily A certified organic, vegan wholefood nutraceutical with daily wholefood essential vitamins from 45 nutraceutical with essential For personal use only organic wholefoods
Slide 17: Activated X Performance (AXP)
AXP Energy Formula A certified organic and vegan proprietary blend of organic Direct To Consumer / Direct To For personal use only wholefoods and wholefood extracts to promote energy production Professionals ATHLETE BENEFITS Certified organic (2 of 3 Products) AXP Power Protein Vegan Clinically tria
Slide 18: How do we distribute?
How do we distribute? For personal use only Distribution network & market Commercial in confidence PG.18
Slide 19: Primary distribution channels
Primary distribution channels Focus on Community Pharmacy and independent health practitioners For personal use only Australian community pharmacies Specialist retailers - independent health Online Selling practitioners • Community pharmacies are Biome • This channel is a non-retail professional • A
Slide 20: Australian Distribution Network
Australian Distribution Network For personal use only Biome Australia currently has over 2000 distribution points, including over 1300 community pharmacies. Within its existing distribution network of pharmacy banner groups, it has access to another 625 community pharmacies. Community Pharmacy Partn
Slide 21: Adjunct Medication Opportunity Australia
Adjunct Medication Opportunity Australia Activated Probiotics Product with adjunct opportunities ATC medication category Medication volume July 2020-June 2021 within the ATC category For personal use only Biome Advanced 10M Probiotic Prescriptions To help restore the balance of beneficial gut per ye
Slide 22: Training and Education Driven Promotion
Training and Education Driven Promotion Unique Education and Service Sales Model Drives For personal use only Sales in Australia, UK and NZ Education-focused promotion • The Biome sales team is a mix of practitioner education consultants and territory managers • Practitioner education consultants un
Slide 23: Financial snapshot
Financial For personal use only snapshot Commercial in confidence PG.23
Slide 24: Quarterly Net Sales and FY21 Sales by Brand
Quarterly Net Sales FY21 Sales by Brand Track record of rapid growth For personal use only Sep Qtr $916k FY21 Net Sales - $2.32m $1,000,000 $800,000 a. p. 78% +1 $600,000 FY20 Net Sales - $833k $400,000 Activated Probiotics COVID19 - Impact 86% ($2m+) $200,000 Activated Nutrients 13% ($292k) 0 AXP -
Slide 25: Business Growth Drivers
Business Growth Drivers ● The strong sales growth in the 2022 financial year has been driven primarily by Biome’s Activated For personal use only Probiotics, live biotherapeutics (probiotics). ● Biome has delivered strong sales growth with unaudited sales of $341,000 in November 2021, resulting in F
Slide 26: Growth Strategy
Growth For personal use only Strategy Expanding the Product Range International Expansion Internalise High Margin Functions Commercial in confidence PG.26
Slide 27: Growth strategies
Growth strategies Products supported by clinical evidence For personal use only Immediate term (12 months) • Focus on sales and marketing to improve sell-through to existing customers • Build on launch of Biome Her Probiotic in Nov 2021 Launch – a female-specific live biotherapeutic probiotic produc
Slide 28: Future EU Expansion
Future EU Expansion Australian and UK practitioner For personal use only ● channels and network enables expansion into EU ● Biome Australia intends to grow its European sales over the next 2-5 years by increasing the number of distributors in the United Kingdom, increasing marketing spend and recrui
Slide 29: Board and Management
Board and Management For personal use only DOMINIQUE FISHER ILARIO FAENZA BLAIR NORFOLK Non-Executive Director Chair Managing Director ● Couples her experience in tech driven businesses with ● Over 30 years of corporate and director experience in ● More than 10 years in the pharmaceutical and natura
Slide 30: Summary
Summary Strategically positioned, driving rapid growth in complementary medicines For personal use only • +178% growth in Net Sales FY21 ($2.3m) vs FY20 ($833k) • Q1 FY22 Annualised Revenue of $3.6m • +100% growth in FY22 YTD Sales (July - Nov 2021) $1.57m vs PCP • 23 products distributed through ov
Slide 31: Appendices
Appendices For personal use only Commercial in confidence PG.31
Slide 32: Appendix – Examples of Clinical Research/Publications
Appendix 1 – Examples of Clinical Research/Publications For personal use only Biome Daily Biome Iron Berggren A, Lazou Ahrén I, Larsson N, Önning G. Randomised, double-blind and Hoppe M, Önning G, Berggren A, Hulthén L. Probiotic strain Lactobacillus plantarum placebo-controlled study using new prob
Slide 33: Appendix - Senior Management
Appendix 2 - Senior Management For personal use only DOUGLAS LOH DR. JAROSLAV BOUBLIK REBECCA EDWARDS Chief Financial Officer Chief Science Officer Education Director ● Douglas holds a Bachelor of Economics (Hons) from the ● B.Sc. (Hons) Chemistry, Monash University, in 1981 ● Speaker, writer, educa
Slide 34: Contact details
For personal use only Contact details: Blair Norfolk, CEO e: blair@activated.co Ilario Faenza, Chair e: ilario@activated.co Websites: biomeaustralia.com activatedprobiotics.com.au activatednutrients.com activatedxperformance.com.au Biome Australia Limited Company Presentation Dec 2021 Commercial in
Biome Australia — Investor Presentation (December 2021) on 6ix